#TieredPricing

[innerparadisementality]

Beyond the Price Tag: How Risk Shapes Negotiations

Introduction In the realm of negotiations, price often grabs the spotlight. However, there’s another critical factor that plays a significant role: risk. The interplay between price and risk can shape the outcome of negotiations in profound ways. In my years of professional work, I must have negotiated thousands of supply agreements. Over time, I grew to understand the deep interconnectivity of…

[carolamandaus]

5 Methods for Monetizing Your Website:

A tiered pricing model allows you to offer different levels of website design services to cater to a broader client base. Create multiple packages, each with varying features and price points. This approach makes your services accessible to clients with different budgets, increasing your chances of landing projects.

[jjbizconsult]

Pricing Models – The popular ones You Need To Know

[allenafol]

Brucklink tiered pricing! Hi all, just to let you know I've added tiered pricing for a load if my bulk items in my store. This means if you wanted to buy a bulk lot then you can save a tonne! Discount is on top of the spending discount so there is up to 40% off if you grab a bulk load of items! store.bricklink.com/allenafol #allenafol #bricklink #tieredpricing #lego #afol #legolove #legolife #legoart #legoselling #shop #discount #legostagram (at Compstall) https://www.instagram.com/p/B8Q1Ew3prv8/?igshid=16gws1wlvzz1x

[ogilvyhealthworldmarketaccess]

Global tiered pricing, a new frontier for pharma

Tiered pricing - the concept of selling a medicine in developing countries at prices systematically lower than in industrialised countries has long since received widespread support from all related parties as a way to improve access to medicines for the poor. However, the correlation between a products price and the local economic conditions has found to be tenuous at best in places.

For some emerging markets, tiered prices are in place in areas such as infectious diseases, diabetes and hypertension. However, there is now a push to expand this to increase patient access to therapeutic innovations for critical illnesses such as breast cancer, stroke and multiple sclerosis, with payers keen to see corresponding tiered prices for treatments of these diseases.

Whilst pharma companies are keen to apply tiered pricing to these therapeutic areas, and have been differentiating prices for new medicines to ensure that socio-economic realities are matched to individual markets for a while now. The patient populations are too small to effectively implement a tiered pricing strategy, and the cost of manufacturing innovative products, particularly in the biotechnology sector, pushes the floor price already out of the range of many emerging economies.

Payers, governments, and non-governmental organisations in emerging markets are not happy, as they believe that the lower prices offered are not low enough. On the other hand, advanced markets, believe they may go too far as they are aware of the discounted prices available to poorer economies and may have these in mind during price negotiations, which can increase the risk associated with global tiered pricing strategies.